Growth investors and dividend collectors alike should consider CERN stock now as the company posts indisputably solid fiscal figures.
As rumors swirl around a possible acquisition for electronic health record company Cerner, consider picking up CERN stock.
These seven risky stocks might take a breather as the bull market enters a more speculative stage in the new quarter. Proceed with caution.
Tech stocks can deliver spectacular growth, but when companies face big challenges and shares start sliding, it may be best to avoid them.
Covid-19 has meant many tech stocks now put more resources in healthcare. These technology shares deserve to be on your radar.
If the insiders are buying, other investors should at least pay attention. These seven stocks are ones to keep an eye on here.
Politics is a wildcard that can negatively impact healthcare stocks. But there are still many top companies with great prospects to consider.
True, there are political risks in the industry. But there are also lots of growth opportunities for investors in healthcare stocks.
The coronavirus has brought much of the world economy to a halt. However, big data could help us defeat this and future pandemics.
Tesla unveiled its new pickup, the Cybertruck, to mixed reactions. Here's what happened in the stock market today.
Cerner layoffs are on the way as the company looks to reduce its workforce and increasing its operating margin for Q4 2019.
With August now upon us, not only is the overbought market vulnerable to profit-taking, the calendar is working against stocks as well. One average, the market loses ground rather than gains ground in the month of August, as well as for September.
When you're looking for promising stocks to buy, paying attention to insider buying can help identify undervalued stocks. Here are five stocks worth noting.
The real scandal isn't the failure of the stimulus but the response, which was to ditch open-source health-IT solutions that worked for proprietary ones that don't.
Put these names on a list of stocks to buy sooner than later. The bears overshot with their pessimism and now may be the time to get in.
Akamai Technologies (AKAM), Cerner (CERN) and Microchip Technology (MCHP) all reported on their latest quarterly earnings after the bell Tuesday.
Cerner Corp (NASDAQ:CERN) ranks in the top 10% of its industry group, Health Care Technology, and in the top decile of sector group, Health Care, with a market value of $23.3 billion. From an investment attractiveness vantage point, CERN is ranked in the top half of the sector with a ranking of 220 among the 782 companies in the sector; the ranking for CERN by Portfolio Grader places it 8 among the 24 companies in this industry group, placing it in the top half and number 1,203 in the 5000 company Portfolio Grader company universe.
Cerner Corp (NASDAQ:CERN) ranks in the top 10% of its industry group, Health Care Technology, and in the top decile of sector group, Health Care, with a market value of $23.3 billion. From an investment attractiveness vantage point, CERN is ranked in the top half of the sector with a ranking of 220 among the 782 companies in the sector; the ranking for CERN by Portfolio Grader places it 8 among the 24 companies in this industry group, placing it in the top half and number 1,203 in the 5000 company Portfolio Grader company universe.
Cerner Corp (NASDAQ:CERN) is ranked as a Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. CERN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.
The current recommendation of Buy for Cerner Corp (NASDAQ:CERN) is the result of using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. CERN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.